Skip to main content

Prelude Therapeutics Inc

PRLD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001678660

No open-market purchases or sales by Prelude Therapeutics Inc insiders were filed in the last 90 days; 75 institutions reported holding it in 13F filings for Q2 2026, worth $264.3M in total; no superinvestor holds it.

13F holders, Q2 2022

Institutional positions in Prelude Therapeutics Inc as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
62
−4 vs. Q1 2022
Shares held
32.7M
−1.31M (−3.9%) vs. Q1 2022
Total value
$170.9M
−$64.1M (−27.3%) vs. Q1 2022
New holders
13
16 more added
Sold out
17
22 more reduced

2 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q1 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting PRLD on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2022: 62 institutions
Q1 2021: 60 institutionsQ2 2021: 57 institutionsQ3 2021: 61 institutionsQ4 2021: 75 institutionsQ1 2022: 68 institutionsQ2 2022: 62 institutionsQ3 2022: 53 institutionsQ4 2022: 60 institutionsQ1 2023: 55 institutionsQ2 2023: 55 institutionsQ3 2023: 60 institutionsQ4 2023: 56 institutionsQ1 2024: 58 institutionsQ2 2024: 61 institutionsQ3 2024: 70 institutionsQ4 2024: 62 institutionsQ1 2025: 59 institutionsQ2 2025: 50 institutionsQ3 2025: 47 institutionsQ4 2025: 48 institutionsQ1 2026: 55 institutionsQ2 2026: 75 institutions
Value heldQ2 2022: $170.9M
Q1 2021: $1.41BQ2 2021: $986.6MQ3 2021: $1.12BQ4 2021: $437.6MQ1 2022: $235.4MQ2 2022: $170.9MQ3 2022: $210.3MQ4 2022: $188.3MQ1 2023: $179.6MQ2 2023: $176.2MQ3 2023: $113.1MQ4 2023: $148.3MQ1 2024: $162.1MQ2 2024: $129.2MQ3 2024: $74.0MQ4 2024: $41.0MQ1 2025: $23.3MQ2 2025: $22.0MQ3 2025: $39.1MQ4 2025: $82.6MQ1 2026: $105.2MQ2 2026: $264.3M
Institutions holding PRLD and their total value by quarter
QuarterHoldersValue
Q2 202675$264.3M
Q1 202655$105.2M
Q4 202548$82.6M
Q3 202547$39.1M
Q2 202550$22.0M
Q1 202559$23.3M
Q4 202462$41.0M
Q3 202470$74.0M
Q2 202461$129.2M
Q1 202458$162.1M
Q4 202356$148.3M
Q3 202360$113.1M
Q2 202355$176.2M
Q1 202355$179.6M
Q4 202260$188.3M
Q3 202253$210.3M
Q2 202262$170.9M
Q1 202268$235.4M
Q4 202175$437.6M
Q3 202161$1.12B
Q2 202157$986.6M
Q1 202160$1.41B

Institutions, Q2 2022

Shares, value and share of portfolio for each institution holding Prelude Therapeutics Inc; share changes are against Q1 2022.

Institutions holding PRLD in Q2 2022
InstitutionSharesValue% of portfolioChange in sharesAction
New York State Common Retirement Fund92$00.00%−4,900−98.2%Reduced
Cutler Group LP100$00.00%00.0%Unchanged
HighMark Wealth Management LLC50$00.00%00.0%Unchanged
Credit Suisse AG6$00.00%+6New
Capital Advisors, Ltd. LLC11$00.00%+11New
Wells Fargo & Company187$1.00K0.00%+87+87.0%Added
Daiwa Securities Group Inc.104$1.00K0.00%00.0%Unchanged
Federated Hermes, Inc.266$1.00K0.00%+266New
Advisor Group Holdings, Inc.500$3.00K0.00%+135+37.0%Added
Citigroup Inc841$4.00K0.00%−878−51.1%Reduced
Brewin Dolphin Wealth Management Ltd1,699$9.00K0.00%00.0%Unchanged
JPMorgan Chase & Co2,033$11.0K0.00%−7,231−78.1%Reduced
Royal Bank of Canada2,501$13.0K0.00%−665−21.0%Reduced
UBS Group AG2,706$14.0K0.00%+2,523+1,378.7%Added
Quantbot Technologies LP2,800$14.0K0.00%+2,800New
Barclays PLC4,060$21.0K0.00%−1,817−30.9%Reduced
Tower Research Capital LLC (TRC)4,024$21.0K0.00%+1,689+72.3%Added
Nisa Investment Advisors, LLC4,000$21.0K0.00%+4,000New
Ensign Peak Advisors, Inc8,080$42.0K0.00%00.0%Unchanged
Corton Capital Inc.15,586$81.0K0.08%+4,668+42.8%Added
Commonwealth Equity Services, LLC16,617$86.0K0.00%−3,850−18.8%Reduced
Delphia (USA) Inc.16,940$88.0K0.06%+16,940New
Schonfeld Strategic Advisors LLC18,000$94.0K0.00%+18,000New
Squarepoint Ops LLC19,618$102.0K0.00%−11,716−37.4%Reduced
Northern Trust Corp21,167$110.0K0.00%−80,739−79.2%Reduced
Occudo Quantitative Strategies LP23,640$123.0K0.01%−598−2.5%Reduced
Virtus ETF Advisers LLC24,005$125.0K0.05%+10,957+84.0%Added
TD Asset Management Inc28,440$148.0K0.00%00.0%Unchanged
Bank of New York Mellon Corp29,189$153.0K0.00%−30,631−51.2%Reduced
Susquehanna International Group, LLP29,428$154.0K0.00%+29,428New
Manufacturers Life Insurance Company, The34,267$177.5K0.00%00.0%Unchanged
Gsa Capital Partners LLP36,626$191.0K0.03%+13,425+57.9%Added
Cubist Systematic Strategies, LLC39,938$208.0K0.00%+39,938New
Ergoteles LLC43,500$227.0K0.01%+43,500New
PDT Partners, LLC43,731$228.0K0.02%−28,091−39.1%Reduced
State Street Corp43,889$229.0K0.00%−165,972−79.1%Reduced
Goldman Sachs Group Inc44,295$232.0K0.00%+20,205+83.9%Added
Marshall Wace, LLP45,716$238.0K0.00%−66,061−59.1%Reduced
Bridgeway Capital Management, LLC46,949$245.0K0.01%+46,949New
Charles Schwab Investment Management Inc63,200$330.0K0.00%−12,730−16.8%Reduced
New York Life Investment Management LLC67,585$353.0K0.00%+67,585New
Caxton Associates LP83,867$438.0K0.05%+83,867New
Millennium Management LLC90,937$475.0K0.00%+51,626+131.3%Added
Citadel Advisors LLC109,623$572.0K0.00%+58,725+115.4%Added
D. E. Shaw & Co., Inc.115,867$605.0K0.00%+92,256+390.7%Added
State of Wisconsin Investment Board127,200$664.0K0.00%+52,700+70.7%Added
Bank of America Corp133,495$697.0K0.00%−1,742−1.3%Reduced
Geode Capital Management, LLC135,641$708.0K0.00%−71,935−34.7%Reduced
Renaissance Technologies LLC160,486$838.0K0.00%+120,386+300.2%Added
Two Sigma Investments, LP223,836$1.17M0.00%+43,424+24.1%Added
Two Sigma Advisers, LP235,700$1.23M0.00%+109,200+86.3%Added
Price T Rowe Associates Inc307,353$1.60M0.00%−15,635−4.8%Reduced
Rock Springs Capital Management LP368,959$1.93M0.06%00.0%Unchanged
Massachusetts Financial Services Co478,525$2.50M0.00%−3,594−0.7%Reduced
Morgan Stanley480,788$2.51M0.00%−65,687−12.0%Reduced
BlackRock Inc.529,435$2.76M0.00%−522,525−49.7%Reduced
HHLR Advisors, Ltd.SuperinvestorHHLR Advisors (Hillhouse)583,333$3.04M0.07%00.0%Unchanged
Vanguard Group Inc899,045$4.69M0.00%+98,547+12.3%Added
UBS Asset Management Americas Inc2,420,527$12.6M0.01%−1,800−0.1%Reduced
FMR LLC4,302,969$22.5M0.00%−1,068,938−19.9%Reduced
OrbiMed Advisors LLC10,039,691$52.4M1.02%00.0%Unchanged
Baker Bros. Advisors LP10,123,824$52.8M0.30%00.0%Unchanged
Nuveen Asset Management, LLC0$00.00%−66,421−100.0%Sold out
Swiss National Bank0$00.00%−29,700−100.0%Sold out
Alliancebernstein L.P.0$00.00%−21,500−100.0%Sold out
California State Teachers Retirement System0$00.00%−15,316−100.0%Sold out
Voloridge Investment Management, LLC0$00.00%−11,743−100.0%Sold out
Rhumbline Advisers0$00.00%−10,050−100.0%Sold out
Deutsche Bank AG0$00.00%−6,187−100.0%Sold out
American International Group, Inc.0$00.00%−5,373−100.0%Sold out
Legal & General Group Plc0$00.00%−3,914−100.0%Sold out
STRS Ohio0$00.00%−2,200−100.0%Sold out
Amalgamated Bank0$00.00%−1,764−100.0%Sold out
Lindbrook Capital, LLC0$00.00%−1,562−100.0%Sold out
Simplex Trading, LLC0$00.00%−1,561−100.0%Sold out
Signaturefd, LLC0$00.00%−992−100.0%Sold out
Ameritas Investment Partners, Inc.0$00.00%−769−100.0%Sold out
Dravo Bay LLC0$00.00%−650−100.0%Sold out
US Bancorp0$00.00%−606−100.0%Sold out
IndexIQ Advisors LLC––––Not filed
Amalgamated Financial Corp.––––Not filed